These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 25283469)
1. Using multiple daily pain ratings to improve reliability and assay sensitivity: how many is enough? Heapy A; Dziura J; Buta E; Goulet J; Kulas JF; Kerns RD J Pain; 2014 Dec; 15(12):1360-5. PubMed ID: 25283469 [TBL] [Abstract][Full Text] [Related]
2. The Number of Ratings Needed for Valid Pain Assessment in Clinical Trials: Replication and Extension. Jensen MP; Castarlenas E; Tomé-Pires C; de la Vega R; Sánchez-Rodríguez E; Miró J Pain Med; 2015 Sep; 16(9):1764-72. PubMed ID: 26178637 [TBL] [Abstract][Full Text] [Related]
3. Reliability and validity of individual and composite recall pain measures in patients with cancer. Jensen MP; Wang W; Potts SL; Gould EM Pain Med; 2012 Oct; 13(10):1284-91. PubMed ID: 22925436 [TBL] [Abstract][Full Text] [Related]
4. Assessment of pain intensity in clinical trials: individual ratings vs composite scores. Jensen MP; Tomé-Pires C; Solé E; Racine M; Castarlenas E; de la Vega R; Miró J Pain Med; 2015 Jan; 16(1):141-8. PubMed ID: 25280226 [TBL] [Abstract][Full Text] [Related]
5. Comparison of daily and weekly retrospectively reported pain intensity in patients with localized and generalized musculoskeletal pain. Giske L; Sandvik L; Røe C Eur J Pain; 2010 Oct; 14(9):959-65. PubMed ID: 20363653 [TBL] [Abstract][Full Text] [Related]
6. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison. Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542 [TBL] [Abstract][Full Text] [Related]
7. Optimizing Pain Intensity Assessment in Clinical Trials: How Many Ratings are Needed to Best Balance the Need for Validity and to Minimize Assessment Burden? de la Vega R; Sakulsriprasert P; Miró J; Jensen MP J Pain; 2024 Jul; 25(7):104474. PubMed ID: 38232864 [TBL] [Abstract][Full Text] [Related]
8. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study. Simpson DM; Messina J; Xie F; Hale M Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282 [TBL] [Abstract][Full Text] [Related]
9. Pain sensitivity can be assessed by self-rating: Development and validation of the Pain Sensitivity Questionnaire. Ruscheweyh R; Marziniak M; Stumpenhorst F; Reinholz J; Knecht S Pain; 2009 Nov; 146(1-2):65-74. PubMed ID: 19665301 [TBL] [Abstract][Full Text] [Related]
10. Single vs composite measures of pain intensity: relative sensitivity for detecting treatment effects. Jensen MP; Hu X; Potts SL; Gould EM Pain; 2013 Apr; 154(4):534-538. PubMed ID: 23375512 [TBL] [Abstract][Full Text] [Related]
11. Chronic pain acceptance questionnaire: confirmatory factor analysis, reliability, and validity in Italian subjects with chronic low back pain. Monticone M; Ferrante S; Rocca B; Nava T; Parini C; Cerri C Spine (Phila Pa 1976); 2013 Jun; 38(13):E824-31. PubMed ID: 23524871 [TBL] [Abstract][Full Text] [Related]
12. Using the patient global assessment of the method of pain control to assess new analgesic modalities in clinical trials. Rothman M; Vallow S; Damaraju CV; Hewitt DJ Curr Med Res Opin; 2009 Jun; 25(6):1433-43. PubMed ID: 19419336 [TBL] [Abstract][Full Text] [Related]
13. Reliability of posturographic measurements in the assessment of impaired sensorimotor function in chronic low back pain. Leitner C; Mair P; Paul B; Wick F; Mittermaier C; Sycha T; Ebenbichler G J Electromyogr Kinesiol; 2009 Jun; 19(3):380-90. PubMed ID: 18023594 [TBL] [Abstract][Full Text] [Related]
14. From codeine to transdermal fentanyl for cancer pain control: a safety and efficacy clinical trial. Mystakidou K; Befon S; Kouskouni E; Gerolymatos K; Georgaki S; Tsilika E; Vlahos L Anticancer Res; 2001; 21(3C):2225-30. PubMed ID: 11501851 [TBL] [Abstract][Full Text] [Related]
16. Validation of two novel electronic devices to time-link transcutaneous electrical nerve stimulation and pain report in patients with chronic back pain. Pallett EJ; Rentowl P; Watson PJ Clin J Pain; 2013 Jan; 29(1):35-42. PubMed ID: 22751031 [TBL] [Abstract][Full Text] [Related]
17. Switching from high doses of pure μ-opioid agonists to transdermal buprenorphine in patients with cancer: a feasibility study. Lundorff L; Sjøgren P; Hansen OB; Jonsson T; Nielsen PR; Christrup L J Opioid Manag; 2013; 9(4):255-62. PubMed ID: 24353018 [TBL] [Abstract][Full Text] [Related]
18. The safety and efficacy of fentanyl iontophoretic transdermal system compared with morphine intravenous patient-controlled analgesia for postoperative pain management: an analysis of pooled data from three randomized, active-controlled clinical studies. Viscusi ER; Siccardi M; Damaraju CV; Hewitt DJ; Kershaw P Anesth Analg; 2007 Nov; 105(5):1428-36, table of contents. PubMed ID: 17959978 [TBL] [Abstract][Full Text] [Related]
19. A Phase III study to assess the clinical utility of low-dose fentanyl transdermal system in patients with chronic nonmalignant pain. Otis J; Rothman M Curr Med Res Opin; 2006 Aug; 22(8):1493-501. PubMed ID: 16870074 [TBL] [Abstract][Full Text] [Related]
20. Postoperative pain intensity assessment: a comparison of four scales in Chinese adults. Li L; Liu X; Herr K Pain Med; 2007 Apr; 8(3):223-34. PubMed ID: 17371409 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]